These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

239 related items for PubMed ID: 11478142

  • 21. Epidermal growth factor receptor signaling enhanced by long-term medroxyprogesterone acetate treatment in endometrial carcinoma.
    Zhao S, Chen X, Lu X, Yu Y, Feng Y.
    Gynecol Oncol; 2007 Apr; 105(1):45-54. PubMed ID: 17240435
    [Abstract] [Full Text] [Related]

  • 22. Effectiveness of high-dose progestin and long-term outcomes in young women with early-stage, well-differentiated endometrioid adenocarcinoma of uterine endometrium.
    Park H, Seok JM, Yoon BS, Seong SJ, Kim JY, Shim JY, Park CT.
    Arch Gynecol Obstet; 2012 Feb; 285(2):473-8. PubMed ID: 21706284
    [Abstract] [Full Text] [Related]

  • 23. The impact of age on long-term outcome in patients with endometrial cancer treated with postoperative radiation.
    Jolly S, Vargas CE, Kumar T, Weiner SA, Brabbins DS, Chen PY, Floyd W, Martinez AA.
    Gynecol Oncol; 2006 Oct; 103(1):87-93. PubMed ID: 16545441
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Pharmacotherapy of endometrial cancer.
    Barrena Medel NI, Bansal S, Miller DS, Wright JD, Herzog TJ.
    Expert Opin Pharmacother; 2009 Aug; 10(12):1939-51. PubMed ID: 19586421
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Ovarian metastasis in a nulliparous woman with endometrial adenocarcinoma failing conservative hormonal treatment.
    Huang SY, Jung SM, Ng KK, Chang YC, Lai CH.
    Gynecol Oncol; 2005 May; 97(2):652-5. PubMed ID: 15863173
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study.
    Keys HM, Roberts JA, Brunetto VL, Zaino RJ, Spirtos NM, Bloss JD, Pearlman A, Maiman MA, Bell JG, Gynecologic Oncology Group.
    Gynecol Oncol; 2004 Mar; 92(3):744-51. PubMed ID: 14984936
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. [Conservative treatment of endometrial cancer as a way to preserve fertility. Five-year experience at Instituto Nacional de Perinatilogía Isidro Espinoza de los Reyes].
    Arteaga Gómez AC, Castellanos Barroso G, Márquez Acosta G.
    Ginecol Obstet Mex; 2012 Jun; 80(6):394-9. PubMed ID: 22826967
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Hormonal therapy of endometrial stromal sarcoma.
    Reich O, Regauer S.
    Curr Opin Oncol; 2007 Jul; 19(4):347-52. PubMed ID: 17545798
    [Abstract] [Full Text] [Related]

  • 39. Hormonal therapy for women with stage IA endometrial cancer of all grades.
    Park JY, Kim DY, Kim TJ, Kim JW, Kim JH, Kim YM, Kim YT, Bae DS, Nam JH.
    Obstet Gynecol; 2013 Jul; 122(1):7-14. PubMed ID: 23743459
    [Abstract] [Full Text] [Related]

  • 40. Intravaginal brachytherapy alone for intermediate-risk endometrial cancer.
    Alektiar KM, Venkatraman E, Chi DS, Barakat RR.
    Int J Radiat Oncol Biol Phys; 2005 May 01; 62(1):111-7. PubMed ID: 15850910
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.